Analysts' average 12-month price target for RXO is $26.
Get informed when a big investor buys or sells
+ Follow$19.79
16 analysts in the last 4 months
High: $35 | Low: $18
No recommendations in the last 4 months.
The latest target price for RXO is $26. Investors often review this figure alongside RXO's historical trend and sector peers before judging valuation or financial health.
RXO trades near $19.79 while the consensus target sits at $26 (29.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.
After noting RXO's target price ($26), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.